Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 3/20 | 0.93 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.93 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.93 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.93 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.93 |
| ▸ | CA1 | P00915 | 3/20 | 0.60 |
| ▸ | CES2 | O00748 | 2/20 | 0.59 |
| ▸ | CES1 | P23141 | 2/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | FABP3 | P05413 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL30561602 | 1.00 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL30561604 | 1.00 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL10908702 | 1.00 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL11430053 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL5049856 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL4816057 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL11429689 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL60746 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL3681545 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 | |
| Butyric Acid SCHEMBL365970 | 0.93 | FFAR3 (0.93) | FFAR3HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210340285-A1 | METHOD FOR PRODUCING HYDROGENATED NITRILE RUBBER AND HNBR COMPOSITIONS THEREOF | ARLANXEO DEUTSCHLAND GMBH (DE) | 2021-11-04 | — | — | US | claimed |
| EP-3827029-A1 | METHOD FOR PRODUCING HYDROGENATED NITRILE RUBBER AND HNBR COMPOSITIONS THEREOF | ARLANXEO Deutschland GmbH (DE) | 2021-06-02 | — | — | EP | claimed |
| CN-112469737-A | Process for producing hydrogenated nitrile rubber and HNBR compositions thereof | 阿朗新科德国有限责任公司 | 2021-03-09 | — | — | CN | claimed |
| WO-2020020677-A1 | METHOD FOR PRODUCING HYDROGENATED NITRILE RUBBER AND HNBR COMPOSITIONS THEREOF | ARLANXEO DEUTSCHLAND GMBH (DE) | 2020-01-30 | — | — | WO | claimed |
| CN-102153488-B | Alpha,beta-diamino acid derivative, synthetic method thereof and application thereof | UNIV EAST CHINA NORMAL | 2014-02-12 | — | — | CN | claimed |
| CN-102153488-A | Alpha,beta-diamino acid derivative, synthetic method thereof and application thereof | UNIV EAST CHINA NORMAL | 2011-08-17 | — | — | CN | claimed |
| CN-101851214-A | Method for synthesizing polyarylation substituted oxazolidine | UNIV EAST CHINA NORMAL | 2010-10-06 | — | — | CN | claimed |
| CN-101538226-A | Method for synthesizing optically active alpha-hydroxyl-beta-phenmethyl-beta-amino acid derivative | UNIV EAST CHINA NORMAL | 2009-09-23 | — | — | CN | claimed |
| CN-101402582-A | Synthesis of alpha-hydroxyl-beta-aminophenol with optical activity | UNIV EAST CHINA NORMAL (CN) | 2009-04-08 | — | — | CN | claimed |
| CN-1176074-C | Multi-substitutent beta-monofluoropyrrole compounds and preparing process thereof | 中国科学院上海有机化学研究所 | 2004-11-17 | — | — | CN | claimed |
| CN-1381445-A | Multi-substitutent beta-monofluoropyrrole compounds and preparing process thereof | SHANGHAI INST ORGANIC CHEM (CN) | 2002-11-27 | — | — | CN | claimed |
| US-5302737-A | Reacting a 1-alkyne with an organosilane and carbon monoxide in a solvent in the presence of a catalyst; hydrosilation by-product inhibition | TRINITY UNIVERSITY (US) | 1994-04-12 | — | — | US | claimed |
| US-5135901-A | A catalyst composition comprising rhodium, ruthenium,and a promoter | EASTMAN CHEMICAL COMPANY (US) | 1992-08-04 | — | — | US | claimed |
| US-5043480-A | Difunctional products from ethylene oxide and synthesis gas | EASTMAN KODAK COMPANY (US) | 1991-08-27 | — | — | US | claimed |
| US-4973741-A | RHODIUM-RUTHENIUM CATALYST, GROUP 5A PROMOTER, CARBONYLATION, HYDROFORMYLATION | EASTMAN KODAK COMPANY (US) | 1990-11-27 | — | — | US | claimed |
| US-4038325-A | REFLUXING WITH RHODIUM COMPOUND IN ALCOHOL | UOP INC. (US) | 1977-07-26 | — | — | US | claimed |
| EP-3437737-B1 | METHOD FOR PREPARING DISPERSION OF METAL-CONTAINING PARTICLES AND METHOD FOR PRODUCING HYDROGENATED CONJUGATED DIENE POLYMER | ZEON CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| US-12534590-B2 | Recycle content cyclobutane diol polyester | EASTMAN CHEMICAL COMPANY (US) | 2026-01-27 | — | — | US | disclosed |
| US-4038325-A | REFLUXING WITH RHODIUM COMPOUND IN ALCOHOL | UOP INC. (US) | 1977-07-26 | — | — | US | disclosed |
| US-3936473-A | COPPER OR NOBLE METAL SALT, OXYGEN AND ORGANIC ACID CATALYST | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534590-B2 | Recycle content cyclobutane diol polyester | PGD, MCCC2, PCCA | FFAR3 90/4885HDAC3 4649/4885HDAC1 4804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.